A new trading day began on Monday, with Kura Oncology Inc (NASDAQ: KURA) stock price up 3.76% from the previous day of trading, before settling in for the closing price of $17.53. KURA’s price has ranged from $7.41 to $24.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -10.26%. With a float of $63.54 million, this company’s outstanding shares have now reached $74.35 million.
In an organization with 142 employees, it is important to assess its efficiency.
Kura Oncology Inc (KURA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Kura Oncology Inc is 16.54%, while institutional ownership is 90.34%. The most recent insider transaction that took place on Jan 30 ’24, was worth 103,980. In this transaction Chief Medical Officer of this company sold 4,825 shares at a rate of $21.55, taking the stock ownership to the 38,817 shares. Before that another transaction happened on Jan 29 ’24, when Company’s Chief Medical Officer sold 7,158 for $17.80, making the entire transaction worth $127,416. This insider now owns 43,642 shares in total.
Kura Oncology Inc (KURA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -10.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.93% during the next five years compared to -3.94% drop over the previous five years of trading.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Here are Kura Oncology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -2.40 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.31 million. That was inferior than the volume of 1.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.94%. Additionally, its Average True Range was 1.05.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 60.42%, which indicates a significant increase from 30.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.95% in the past 14 days, which was lower than the 80.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.70, while its 200-day Moving Average is $13.64. However, in the short run, Kura Oncology Inc’s stock first resistance to watch stands at $18.94. Second resistance stands at $19.69. The third major resistance level sits at $20.20. If the price goes on to break the first support level at $17.68, it is likely to go to the next support level at $17.17. The third support level lies at $16.42 if the price breaches the second support level.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
With a market capitalization of 1.38 billion, the company has a total of 76,181K Shares Outstanding. Currently, annual sales are 0 K while annual income is -152,630 K. The company’s previous quarter sales were 0 K while its latest quarter income was -42,790 K.
